Notice of the General Department of the State Food and Drug Administration on Launching the "National Safe Drug Use Month" in 2023
release time:2023-12-12
The Drug Administration of all provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps, and relevant units:
In order to fully implement the spirit of the 20th National Congress of the Communist Party of China, thoroughly implement the spirit of the National Propaganda, Ideological and Cultural Work Conference and the relevant requirements of the "Implementation Opinions of the General Office of the State Council on Comprehensively Strengthening the Capacity Building of Drug Supervision", in accordance with the work deployment of the State Food and Drug Administration, this year will continue to hold "National Safe Drug Month" (hereinafter referred to as "Safety Month") activities. The relevant matters are hereby notified as follows:
1. schedule
The "Safety Month" in 2023 will be held from mid-November to mid-December. During this period, local "safety month" activities should be organized around the theme of the activity, and the launching ceremony should be held before the end of November.
2. activity theme
The theme of the 2023 "Safety Month" activity is "Safe Medication and Health for the People".
3. publicity focus
2023 is the first year to fully implement the spirit of the 20th National Congress of the Communist Party of China, and an important year for the start of building a modern socialist country in an all-round way. According to the work deployment of the State Food and Drug Administration, this year's "Safety Month" activity will focus on the key work of the State Food and Drug Administration, publicize the concept and knowledge of safe drug use through various forms, and build a social consensus on drug safety.
(I) publicity and drug administration departments to fully implement the spirit of the party's 20 major work progress. Focus on publicizing the progress made by the drug regulatory departments in implementing the major decisions and arrangements of the 20th CPC National Congress and the principles and policies of the CPC Central Committee on drug supervision, and in strengthening supervision, preventing risks, promoting development, serving the people's livelihood, and enhancing capacity.
(II) publicize the results of key drug regulatory efforts. Focusing on the "Measures for the Administration of Drug Standards", "Measures for the Quality Supervision and Administration of Drug Operation and Use", "Special Regulations on the Administration of Traditional Chinese Medicine Registration" and other regulatory documents, multi-angle and in-depth policy interpretation and regulatory publicity are carried out. Vigorously publicize the key work of drug supervision, such as the construction of drug supervision capacity, the consolidation and promotion of drug safety, and the inheritance and innovation and development of traditional Chinese medicine, so as to show the effectiveness of drug supervision in promoting the high-quality development of the pharmaceutical industry, and enhance the public's awareness and confidence in China's drug supervision.
(III) carry out the safety of drug popularization. In combination with the study and implementation of Xi Jinping's theme education of socialism with Chinese characteristics in the new era, we should promote the transformation of the achievements of the theme education, publicize the scientific knowledge of safe drug use through various forms, interpret and popularize the safe drug use of the public, especially children, pregnant and lactating women, the elderly and other special groups, and advocate healthy life concepts and lifestyles in the whole society. Further improve the scientific literacy of drug safety of the public.
4. Activity Requirements
(I) strengthen organizational leadership. All localities refer to the "2023" National Safe Drug Month "Key Activity Arrangements" (see annex) and combine local conditions to organize and plan "Safety Month" related activities. Encourage and guide social organizations, medical institutions, scientific research institutions, large enterprises, news media, and popular science organizations to actively participate in activities.
(II) enhance the effectiveness of activities. All localities have strengthened the integration and promotion of traditional media such as radio, television, newspapers and periodicals and new media such as "two micro and one end", so as to effectively form a pattern of full media coverage. We should closely follow the law of communication and public concern, use the unified "safety month" logo, enrich and improve the publicity content and form, and mobilize the public to actively participate in the "drug safety network knowledge competition".
(III) strict disciplinary requirements. All localities strictly implement the spirit of the eight central regulations, persevere in opposing the "four winds", strictly practice diligence and thrift, and follow lightly in activities, and strictly prohibit extravagance, extravagance, and formalism.
(IV) lessons learned. All localities should pay attention to summarizing the effectiveness and experience of the "Safety Month" activities, summarize the activities in a timely manner, and submit a summary report before December 22, 2023.
Activity Management Office: Beijing Zhonghui Digital Intelligence Pharmaceutical Technology Co., Ltd. (formerly Science and Technology Development Center of China Pharmaceutical Association)
Contact: Zhang Lei
Telephone:13581656434
Mailbox:kpb@cpa.org.cn
General Division of the State Food and Drug Administration
Contact: Zhou Yaqi
Telephone:010-88330787
Annex: Arrangements for Key Activities of "National Safe Drug Use Month" in 2023
General Division of the State Food and Drug Administration
27 October 2023
Related News
Contact Information
Contact Phone
Address: Building 3, No. 1, Kaiyuan Road, Yong'an Industrial Cluster Zone, Fuying Street, Xianju County, Taizhou City, Zhejiang Province